AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 175 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.52 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $674,000 | +753.2% | 44,561 | +324.3% | 0.00% | – |
| Q2 2022 | $79,000 | -83.4% | 10,502 | -80.0% | 0.00% | -100.0% |
| Q1 2022 | $477,000 | +29.6% | 52,400 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $368,000 | -38.4% | 52,400 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $597,000 | -28.8% | 52,400 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $839,000 | -10.4% | 52,400 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $936,000 | -51.6% | 52,400 | -63.4% | 0.00% | -50.0% |
| Q4 2020 | $1,933,000 | +178.9% | 143,058 | +142.9% | 0.00% | +100.0% |
| Q3 2020 | $693,000 | -20.3% | 58,900 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $869,000 | -12.0% | 58,900 | -19.4% | 0.00% | -33.3% |
| Q1 2020 | $987,000 | -35.5% | 73,100 | +15.5% | 0.00% | -25.0% |
| Q4 2019 | $1,530,000 | +25.7% | 63,300 | 0.0% | 0.00% | +33.3% |
| Q3 2019 | $1,217,000 | -20.2% | 63,300 | +22.7% | 0.00% | -25.0% |
| Q2 2019 | $1,525,000 | -32.6% | 51,600 | +8.4% | 0.00% | -33.3% |
| Q1 2019 | $2,261,000 | +70.6% | 47,600 | +29.7% | 0.01% | +50.0% |
| Q4 2018 | $1,325,000 | -40.5% | 36,700 | +1.4% | 0.00% | -33.3% |
| Q3 2018 | $2,228,000 | -8.9% | 36,200 | 0.0% | 0.01% | -14.3% |
| Q2 2018 | $2,445,000 | +39.1% | 36,200 | +11.7% | 0.01% | +40.0% |
| Q1 2018 | $1,758,000 | -9.2% | 32,400 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $1,936,000 | +73.2% | 32,400 | +40.9% | 0.01% | +66.7% |
| Q3 2017 | $1,118,000 | -7.5% | 23,000 | 0.0% | 0.00% | -25.0% |
| Q2 2017 | $1,209,000 | – | 23,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |